ganaxolone

FDA Drug Profile — ZTALMY

Drug Details

Generic Name
ganaxolone
Brand Names
ZTALMY
Application Number
NDA215904
Sponsor
Immedica Pharma US Inc
NDC Codes
1
Dosage Forms
SUSPENSION
Routes
ORAL
Active Ingredients
GANAXOLONE

Indications and Usage

1 INDICATIONS AND USAGE ZTALMY is indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older. ZTALMY is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older. ( 1 )